CONCLUSIONS
US-guided PLB in an outpatient setting has a low rate of complications
and must keep been considered for selected individuals with
indeterminate liver disease. The reason to perform it is undergoing a
notable transition, where HCV chronic infection has been replaced by
MAFLD. New strategies to prevent biopsy-related pain are still needed,
especially for females.
Figure legends :
Figure 1 – Number of indications-related liver biopsies from
2015 to 2019 . AIH: autoimmune hepatitis; MAFLD: metabolic
dysfunction-associated fatty liver disease.